U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
DEMUPITAMAB
INN  
Official Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB)), HOMO SAPIENS MONOCLONAL ANTIBODY
Common Name English
N63AB
Common Name English
demupitamab [INN]
Common Name English
IMMUNOGLOBULIN IGG1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL N63AB .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL N63AB .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
FDA UNII
3184JGF2SO
Created by admin on Sat Dec 16 15:24:59 GMT 2023 , Edited by admin on Sat Dec 16 15:24:59 GMT 2023
PRIMARY
CAS
2249926-74-5
Created by admin on Sat Dec 16 15:24:59 GMT 2023 , Edited by admin on Sat Dec 16 15:24:59 GMT 2023
PRIMARY
INN
11211
Created by admin on Sat Dec 16 15:24:59 GMT 2023 , Edited by admin on Sat Dec 16 15:24:59 GMT 2023
PRIMARY
NCI_THESAURUS
C175767
Created by admin on Sat Dec 16 15:24:59 GMT 2023 , Edited by admin on Sat Dec 16 15:24:59 GMT 2023
PRIMARY
SUBSTANCE RECORD
DEMUPITAMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966